Glu17 on protein AKT1 plays an important role during ligand-binding (PDB ID: 1H10) [53], which is a highly frequent, mutated residue in multiple cancer types, including breast, skin melanoma, lung, and colon cancers (Figure 2B and Additional file 1: Table S1). This evidence concerns the gene AKT1 and colonic neoplasm.